Gus DeMoraes's guest appearances

Gus DeMoraes

Talking About Glaucoma (AAC)

Talking About Glaucoma (mp3)

Steve Sarkisian

Robert Schertzer

Josh Ehrlich

Nelson Winkler

Dale Heuer

Marcelo Nicolela

Karim Damji

Suman Thapa

Richard Hom

GEDDE Steve

SIEGFRIED Carla

OwlTail

Talking About Glaucoma #16 for late July 2011 - Dr Gus De Moraes, Risk factors for VF Progression in glaucoma patientsIn this episode, Dr De Moraes and I discuss risk factors for visual field progression in patients already diagnosed with and being treated for glaucoma. Dr De Moraes’ group found that patients with established glaucoma were more likely to progress when peak IOP was 18 mm Hg (millimeters of mercury) or higher. Other risk factors included thinning of the cornea, presence of disc hemorrhage in the retina of the eye, and atrophy in part of the eye.This study was supported by the Joseph and Geraldine LaMotta Research Fund of the New York Glaucoma Research Institute, and one investigator’s work was supported by the Glaucoma Research and Education Fund of Lenox Hill Hospital; both institutions are located in New York. Please see the article in Archives of Ophthalmology cited in these notes for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support.Dr Gustavo De Moraes is Associate Professor of Ophthalmology at the New York University School of Medicine.Dr De Moraes’ constact information:Gustavo De Moraes, M.D. New York Eye and Ear Infirmary310 East 14th StreetNew York, NY 10003Tel:  (212) 477-7540 Extension: 375email: gustavonyee@gmail.comhttp://www.med.nyu.edu/people/demorc02.htmlThis episode was recorded live in March 2011 during the American Glaucoma Society annual meeting using a Shure SM58 microphone with a Marantz PMD661 digital recorder. Mixing and sound levelling were performed on a MacBook Pro and MacBook Air using Levelator, Fission, and Garage Band. Narration was overdubbed using a Blue Microphone Yeti. Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.—————————————————————————Selected reference:Arch Ophthalmol. 2011;129[5]:562-568. (http://archopht.ama-assn.org/cgi/content/abstract/129/5/562)  Robert M Schertzer, MD, MEd, FRCSCClinical Associate ProfessorDept of Ophthalmology &amp; Visual SciencesUniversity of British Columbiapodcast@iguy.orghttp://iguy.tv/podcasthttp://iguy.tv is now set-up as a page to connect you to all my bits and bytes all over the web; go to that landing page as a convenient one-stop hub to all my activitiesWork -    http://westcoastglaucoma.comor http://iguy.tv/officeTwitter - http://twitter.com/robschertzeror http://iguy.tv/twitterBlog -     http://wholelottarob.comor http://iguy.tv/blog © Robert M Schertzer MD Inc, 2011

Talking About Glaucoma #16 for late July 2011 - Dr Gus De Moraes, Risk factors for VF Progression in glaucoma patientsIn this episode, Dr De Moraes and I discuss risk factors for visual field progression in patients already diagnosed with and being treated for glaucoma. Dr De Moraes’ group found that patients with established glaucoma were more likely to progress when peak IOP was 18 mm Hg (millimeters of mercury) or higher. Other risk factors included thinning of the cornea, presence of disc hemorrhage in the retina of the eye, and atrophy in part of the eye. This study was supported by the Joseph and Geraldine LaMotta Research Fund of the New York Glaucoma Research Institute, and one investigator’s work was supported by the Glaucoma Research and Education Fund of Lenox Hill Hospital; both institutions are located in New York. Please see the article in Archives of Ophthalmology cited in these notes for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support. Dr Gustavo De Moraes is Associate Professor of Ophthalmology at the New York University School of Medicine. Dr De Moraes’ constact information: Gustavo De Moraes, M.D. New York Eye and Ear Infirmary 310 East 14th Street New York, NY 10003 Tel:  (212) 477-7540 Extension: 375 email: <a href="mailto:gustavonyee@gmail.com">gustavonyee@gmail.com</a> <a href="http://www.med.nyu.edu/people/demorc02.html" rel="nofollow" target="_blank">http://www.med.nyu.edu/people/demorc02.html</a> This episode was recorded live in March 2011 during the American Glaucoma Society annual meeting using a Shure SM58 microphone with a Marantz PMD661 digital recorder. Mixing and sound levelling were performed on a MacBook Pro and MacBook Air using Levelator, Fission, and Garage Band. Narration was overdubbed using a Blue Microphone Yeti. Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care. ————————————————————————— Selected reference: Arch Ophthalmol. 2011;129[5]:562-568. (<a href="http://archopht.ama-assn.org/cgi/content/abstract/129/5/562" rel="nofollow" target="_blank">http://archopht.ama-assn.org/cgi/content/abstract/129/5/562</a>) Robert M Schertzer, MD, MEd, FRCSC Clinical Associate Professor Dept of Ophthalmology &amp; Visual Sciences University of British Columbia <a href="mailto:podcast@iguy.org">podcast@iguy.org</a> <a href="http://iguy.tv/podcast" rel="nofollow" target="_blank">http://iguy.tv/podcast</a><a href="http://iguy.tv/" rel="nofollow" target="_blank">http://iguy.tv</a> is now set-up as a page to connect you to all my bits and bytes all over the web; go to that landing page as a convenient one-stop hub to all my activitiesWork -    <a href="http://westcoastglaucoma.com/" rel="nofollow" target="_blank">http://westcoastglaucoma.com</a> or <a href="http://iguy.tv/office" rel="nofollow" target="_blank">http://iguy.tv/office</a> Twitter - <a href="http://twitter.com/robschertzer" rel="nofollow" target="_blank">http://twitter.com/robschertzer</a> or <a href="http://iguy.tv/twitter" rel="nofollow" target="_blank">http://iguy.tv/twitter</a> Blog -     <a href="https://rob-schertzer.squarespace.com/" rel="nofollow" target="_blank">http://wholelottarob.com</a> or <a href="http://iguy.tv/blog" rel="nofollow" target="_blank">http://iguy.tv/blog</a> © Robert M Schertzer MD Inc, 2011

Ep 16 Talking About Glaucoma - 26Jul2011 VF progression risk fx with Gus DeMoraes (mp3)

Talking About Glaucoma #16 for late July 2011 - Dr Gus De Moraes, Risk factors for VF Progression in glaucoma patients In this episode, Dr De Moraes and I discuss risk factors for visual field progression in patients already diagnosed with and being treated for glaucoma. Dr De Moraes’ group found that patients with established glaucoma were more likely to progress when peak IOP was 18 mm Hg (millimeters of mercury) or higher. Other risk factors included thinning of the cornea, presence of disc hemorrhage in the retina of the eye, and atrophy in part of the eye. This study was supported by the Joseph and Geraldine LaMotta Research Fund of the New York Glaucoma Research Institute, and one investigator’s work was supported by the Glaucoma Research and Education Fund of Lenox Hill Hospital; both institutions are located in New York. Please see the article in Archives of Ophthalmology cited in these notes for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support. Dr Gustavo De Moraes is Associate Professor of Ophthalmology at the New York University School of Medicine. Dr De Moraes’ constact information: Gustavo De Moraes, M.D. New York Eye and Ear Infirmary 310 East 14th Street New York, NY 10003 Tel:  (212) 477-7540 Extension: 375 email: <a href="mailto:gustavonyee@gmail.com">gustavonyee@gmail.com</a> <a href="http://www.med.nyu.edu/people/demorc02.html" rel="nofollow" target="_blank">http://www.med.nyu.edu/people/demorc02.html</a> This episode was recorded live in March 2011 during the American Glaucoma Society annual meeting using a Shure SM58 microphone with a Marantz PMD661 digital recorder. Mixing and sound levelling were performed on a MacBook Pro and MacBook Air using Levelator, Fission, and Garage Band. Narration was overdubbed using a Blue Microphone Yeti. Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care. ————————————————————————— Selected reference: Arch Ophthalmol. 2011;129[5]:562-568. (<a href="http://archopht.ama-assn.org/cgi/content/abstract/129/5/562" rel="nofollow" target="_blank">http://archopht.ama-assn.org/cgi/content/abstract/129/5/562</a>) Robert M Schertzer, MD, MEd, FRCSC Clinical Associate Professor Dept of Ophthalmology &amp; Visual Sciences University of British Columbia <a href="mailto:podcast@iguy.org">podcast@iguy.org</a> <a href="http://iguy.tv/podcast" rel="nofollow" target="_blank">http://iguy.tv/podcast</a><a href="http://iguy.tv/" rel="nofollow" target="_blank">http://iguy.tv</a> is now set-up as a page to connect you to all my bits and bytes all over the web; go to that landing page as a convenient one-stop hub to all my activitiesWork -    <a href="http://westcoastglaucoma.com/" rel="nofollow" target="_blank">http://westcoastglaucoma.com</a> or <a href="http://iguy.tv/office" rel="nofollow" target="_blank">http://iguy.tv/office</a> Twitter - <a href="http://twitter.com/robschertzer" rel="nofollow" target="_blank">http://twitter.com/robschertzer</a> or <a href="http://iguy.tv/twitter" rel="nofollow" target="_blank">http://iguy.tv/twitter</a> Blog -     <a href="https://rob-schertzer.squarespace.com/" rel="nofollow" target="_blank">http://wholelottarob.com</a> or <a href="http://iguy.tv/blog" rel="nofollow" target="_blank">http://iguy.tv/blog</a> © Robert M Schertzer MD Inc, 2011

Ep 16 - Talking About Glaucoma - 26Jul2011 VF progression risk fx with Gus DeMoraes (AAC)